Minerva Neurosciences, Inc. - 10-Q Filing

Minerva Neurosciences reports Q3 2026 financial results featuring significant warrant liability valuations and ongoing equity programs.

3 articles from 1 source · updated November 9, 2026, 22:11 UTC

Coverage

• Aspen Neuroscience, Inc. - 4 Filing SEC EDGAR · November 9, 2026, 22:10 UTC
• OCULAR THERAPEUTIX, INC - 10-Q Filing SEC EDGAR · November 9, 2026, 12:19 UTC
• Minerva Neurosciences, Inc. - 10-Q Filing SEC EDGAR · November 6, 2026, 21:00 UTC